ArticleOne health (Amsterdam, Netherlands)2026
Life-history traits associated to West Nile virus seroprevalence in wild birds: Lessons from the recent outbreaks in Spain.
Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
West Nile virus (WNV) is a vector-borne zoonotic pathogen maintained in a bird-mosquito cycle, occasionally infecting humans and horses. It is considered a re-emerging pathogen in Europe, with recurrent outbreaks recently reported in Spain. However, the ecological and evolutionary factors driving spatio-temporal variation in WNV incidence remain unclear. To address this, we analysed a long-term dataset of the presence of WNV neutralizing antibodies in 19,105 serum samples from 48 avian species. Blood samples were collected from birds in southern Spain over two decades, between 2003 and 2024, encompassing periods with varying human WNV incidence. Using phylogenetically informed models, we analysed the ecological and life-history traits associated with WNV seroprevalence in wild birds. Age, phylogeny, locality, and year explained significant variation in seroprevalence. Among first-year individuals, urban-associated species showed higher WNV seroprevalence than species inhabiting forest or shrubland habitats, and it varied significantly based on primary lifestyle. In adults, seroprevalence also correlated positively with body mass and negatively with beak length. Notably, WNV seroprevalence in urban birds increased significantly during years with human outbreak, whereas no such association was found in birds from non-urban habitats. These results suggest that the complexity of WNV cycles may be partly unravelled by incorporating data on avian ecology and phylogeny. In addition, we provide evidence of active virus circulation inside the cities during WNV human outbreaks and suggest the potential of urban bird species as epidemiological sentinels for human outbreaks. Overall, this study underscores the importance of a One Health approach to understand vector-borne zoonotic pathogen dynamics and to inform effective surveillance and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.